Autonomix Medical induces exercise of warrants for $4.9 million gross proceeds
AMIX•Expected closing
Closing is expected on or about Aug. 26, 2026, subject to customary conditions.
Incentive warrants and registration plans
The incentive includes unregistered Series E-1 warrants for 535,913 shares and unregistered Series E-2 warrants for 535,913 shares; exercise price $6.25.
The new warrants will be exercisable on issuance and will expire five years from issuance. The company said it will file with the SEC a registration statement for the resale shares.
Warrant inducement expected to raise about $4.9 million
Autonomix Medical entered a warrant inducement for immediate cash exercise of July 2026 Warrants for 857,462 shares at $5.75.
Gross proceeds are expected to be about $4.9 million, before fees.
